Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA.
Genetics. 2010 Apr;184(4):1165-79. doi: 10.1534/genetics.109.112516. Epub 2010 Jan 25.
Protein aggregates are a common pathological feature of most neurodegenerative diseases (NDs). Understanding their formation and regulation will help clarify their controversial roles in disease pathogenesis. To date, there have been few systematic studies of aggregates formation in Drosophila, a model organism that has been applied extensively in modeling NDs and screening for toxicity modifiers. We generated transgenic fly lines that express enhanced-GFP-tagged mutant Huntingtin (Htt) fragments with different lengths of polyglutamine (polyQ) tract and showed that these Htt mutants develop protein aggregates in a polyQ-length- and age-dependent manner in Drosophila. To identify central regulators of protein aggregation, we further generated stable Drosophila cell lines expressing these Htt mutants and also established a cell-based quantitative assay that allows automated measurement of aggregates within cells. We then performed a genomewide RNA interference screen for regulators of mutant Htt aggregation and isolated 126 genes involved in diverse cellular processes. Interestingly, although our screen focused only on mutant Htt aggregation, several of the identified candidates were known previously as toxicity modifiers of NDs. Moreover, modulating the in vivo activity of hsp110 (CG6603) or tra1, two hits from the screen, affects neurodegeneration in a dose-dependent manner in a Drosophila model of Huntington's disease. Thus, other aggregates regulators isolated in our screen may identify additional genes involved in the protein-folding pathway and neurotoxicity.
蛋白质聚集体是大多数神经退行性疾病(NDs)的常见病理特征。了解它们的形成和调节将有助于阐明它们在疾病发病机制中的争议作用。迄今为止,在果蝇中,对聚集体形成的系统研究很少,果蝇是一种广泛应用于模拟 NDs 和筛选毒性调节剂的模式生物。我们生成了表达具有不同长度聚谷氨酰胺(polyQ)片段的增强 GFP 标记突变亨廷顿(Htt)片段的转基因果蝇系,并表明这些 Htt 突变体以 polyQ 长度和年龄依赖性方式在果蝇中形成蛋白质聚集体。为了鉴定蛋白质聚集的中央调节剂,我们进一步生成了表达这些 Htt 突变体的稳定果蝇细胞系,并建立了一种基于细胞的定量测定法,允许自动测量细胞内的聚集体。然后,我们进行了全基因组 RNA 干扰筛选以鉴定突变 Htt 聚集的调节剂,并分离出 126 个涉及各种细胞过程的基因。有趣的是,尽管我们的筛选仅集中在突变 Htt 聚集上,但鉴定出的几个候选基因以前是 NDs 的毒性调节剂。此外,调节 hsp110(CG6603)或 tra1 的体内活性,这是筛选中的两个命中,以剂量依赖的方式影响亨廷顿病果蝇模型中的神经变性。因此,我们在筛选中分离出的其他聚集体调节剂可能会鉴定出更多参与蛋白质折叠途径和神经毒性的基因。